| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥3.20B | +23.7% |
| Gross profit | ¥0.85B | — |
| Operating income | ¥0.28B | — |
| Net income | ¥0.19B | +13.3% |
| Gross margin | 26.6% | Net margin 6.0% |
| Revenue Q/Q | -47.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥2.35B | 73.4% |
| R&D | ¥0.59B | 18.5% |
| SG&A | ¥0.26B | 8.0% |
| Tax & other | ¥0.08B | 2.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新 ・ 洛阳钼业 ・ 德业股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies